-
Research Groups
Clinical Research
-
Vincan Group
Elizabeth’s group investigates novel ways to block cancer growth with a focus on the gastrointestinal tract – stomach, bowel and liver. A cell-cell communication pathway called Wnt is hyperactive in these cancers. Their research shows inhibiting Wnt has potent anti-cancer effects.
Other work areas include: Immunology
Current Projects
-
Elizabeth Vincan Project A
Infection of liver cells with HBV can ultimately lead to liver cancer. The vast majority of HBV related liver cancers also harbour abnormally active Wnt signalling. However, our understanding of the interplay between these two oncogenic drivers of liver cancer is not well understood. This is primarily because HBV only infects normal human liver cells (hepatocytes). Thus, the study of HBV entry into, and natural infection of, human hepatocytes has been hampered by a lack of suitable models. Elizabeth’s group recently established an in vitro mini-liver organoid culture system that supports HBV infection and investigates the oncogenic interplay with Wnt.
-
Elizabeth Vincan Project B
Adult stem cells are the cell-of-origin of cancer. Stem cells are absolutely dependent on tightly controlled Wnt signalling, however, these cells initiate cancer if the Wnt pathway is abnormally switched on. Elizabeth’s research shows that the level of Wnt activity in the cancer cells is critical to cancer growth and that this level is modulated by additional signalling from the Wnt receptor complex. Using mini-gut and mini-stomach organoid technology developed by her collaborators, Professors Hans Clevers and Nick Barker, her group demonstrated potent anti-tumour effects by blocking Wnt receptors. This is being developed as targeted therapy for gastrointestinal cancers.
Lab Team
-
Deputy Section Head of Molecular Microbiology/Head of Molecular Oncology Laboratory
-
Research Fellow
-
Research Fellow
-
Jean MoselenMedical Scientist
-
Bang Tran ManhPhD Student
-
Damian NeateTechnical Assistant
-
Bowden Group
Scott’s laboratory is the State Reference Laboratory for molecular testing of the hepatitis viruses and has been involved in outbreak investigation of hepatitis A, B, C and E for the Victorian Department of Health, as well as for other Australian states.
-
Cowie Group
Ben’s group focuses on viral hepatitis epidemiological research. The team undertakes a broad range of activities supporting local, national and global control of viral hepatitis, through surveillance, treatment and prevention initiatives, and training and regional capacity building.
Other work areas include: Public Health
-
Lewin/Cameron Group
The main focus of the Lewin-Cameron laboratory is to understand why HIV infection persists on antiretroviral therapy, to develop new strategies to eliminate latency and to define the biological determinants of immune reconstitution and factors that drive liver disease in HIV-hepatitis B virus co-infection.
Other work areas include: HIV, Immunology
-
Locarnini Group
The current major research interests of Stephen’s group includes viral hepatitis and antiviral chemotherapy with an emphasis on the basic virology of hepatitis B virus, the molecular pathogenesis of hepatitis, as well as prevention and public health control measures.
-
Nicholson Group
Suellen's group fulfills a dual mission of providing a technically first class, reliable diagnostic, reference and public health service to the healthcare system, and being an innovative, adaptable, forward-looking component of the scientific community and a valued collaborator in research projects, not just in Victoria, but nationally and in the region.
Other work areas include: HIV
-
Revill Group
Peter’s group investigates the role of different HBV genotypes and variants in the HBV life cycle, disease progression and treatment response. This includes the role of splice variants, which his team has shown are predictive of liver cancer.
-
Walsh Group
Renae’s group studies key HBV proteins to predict clinical response during chronic disease towards understanding the interaction with/recognition by the host antibody response to clear infection, and how the antibody response might be enhanced to promote viral clearance and cure.
Now recruiting volunteers
There are currently no Now recruiting volunteers
Current projects
-
Hepatitis HIV
A surveillance program for the detection of hepatitis B virus (HBV) resistance to tenofovir (TDF) in HIV-HBV co-infected patient
-
Hepatitis
Characterising Hepatitis B in northern Australia through Molecular epidemiology - longitudinal cohort study
-
Hepatitis
Liver Cancer Prevention: linking viral hepatitis diagnosis, treatment and outcomes
-
Hepatitis HIV
Long-term persistence of HIV in the liver and the clinical impact on HIV-HBV co-infection (CHHANEL)
-
Hepatitis HIV
Towards a Functional cure for HBV: exploiting lessons from HBV-HIV co-infection
-
